A Phase II Trial of Preoperative Chemoradiotherapy with Oral DPD-Inhibitory Fluoropyrimidines in Patients with Advanced Rectal Cancer

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"A Phase II Trial of Preoperative Chemoradiotherapy with Oral DPD-Inhibitory Fluoropyrimidines in Patients with Advanced Rectal Cancer"
written by Masanori Hotchi, Hiroshi Okitsu, Murato Miura, Madoka Hamada, Yasuhide Sonaka, Yoh Fukuda, Tsutomu Ando, Shinji Kuratate,
published by Journal of Cancer Therapy, Vol.3 No.6A, 2012

has been cited by the following article(s):

[1]	Long-term outcomes and prognostic factors of preoperative chemoradiotherapy with oral dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines in patients …
	2024

[2]	A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer
	2021

[3]	Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer
	Oncology reports, 2015

[1]	MRI navigation surgery, including lateral pelvic lymph node dissection following chemoradiotherapy, improves local control and functional preservation of the middle to low rectal cancer Surgical Oncology, 2024 DOI:10.1016/j.suronc.2024.102093

[2]	A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer International Journal of Clinical Oncology, 2021 DOI:10.1007/s10147-021-01868-1

[3]	Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer Oncology Reports, 2015 DOI:10.3892/or.2015.4196